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The single oral administration of red ginseng oil (5000 mg/kg) to SpragueeDawley rats induced no
changes in behavioral patterns, clinical signs, and body weight, and hepatotoxicity parameters such as
aspartate aminotransferase and alanine aminotransferase for 14 d. Therefore, these results suggest that
the red ginseng oil is safe and nontoxic acutely.
opyright  2013, The Korean Society of Ginseng, Published by Elsevier. Open access under CC BY-NC-ND license. The use of traditional and herbal medicine is practiced in the
prevention, diagnosis, and treatment of diseases, and maintenance
of health, and numerous studies have reported the beneﬁts of
traditional herb medicines [1e5]. Despite the worldwide use of
traditional medicine, there have been concerns about the lack of
safety information. An important role of safety is to identify the
poison that induces the adverse effects involved in the interaction
between toxicants and the cells. The target organs that are affected
may vary depending on the chemical properties of the toxicants
and the cells [6]. Hence, evaluation of safety studies helps us decide
whether or not a new herbal medicine should be adopted for
clinical use. Therefore, an acute oral safety study is vitally needed
not only to identify the range of doses that could be used subse-
quently, but also to reveal the possible clinical signs elicited by the
substances under investigation.
Ginseng (Panax ginsengMeyer) is a widely used traditional herb
medicine [7e10]. There are several types of ginseng depending on
the processing methods, including fresh ginseng, white ginseng,
and red ginseng. Red ginseng is a type of steamed and dried ginseng
that shows enhanced pharmacological effects compared with
nonsteamed ginseng [11e14]. However, these diverse beneﬁcial
effects of red ginseng have been reported mainly with its water-
soluble fractions, probably because red ginseng is widely consumedife Sciences, College of Biomedical
inseng, Published by Elsevier.Openin the form of hot-water extract or its concentrates. The biological
effects of the lipid soluble moiety of red ginseng have been little
studied. We have recently demonstrated various biological activ-
ities and the underlying molecular mechanisms of red ginseng oil
that was prepared by a supercritical CO2 extraction of marc
generated after hot water extraction of red ginseng [15,16]. Red
ginsengmarc oil (RMO) has been shown to have potent antioxidant,
hepatoprotective, and anti-inﬂammatory effects in cells and mice.
Recently, several studies have demonstrated the nontoxic effects of
ginseng in animals and human studies [17e20]. Lee et al [21] re-
ported that black ginseng produced by heat processing is nontoxic
in an acute oral toxicity study. However, little is known about the
safety and/or toxicity of red ginseng oil.
In this study, a single oral dose safety on RMO in Spraguee
Dawley (SD) rats was conducted as the ﬁrst step of safety evalua-
tion, which will provide preliminary safety information regarding
red ginseng oil.
Five-wk-old male and female SD rats from Hyochang Science
(Daegu, South Korea) were used after a 1-wk acclimation to the
laboratory environment. The experiment was performed in the
animal laboratory under the following conditions: temperature
25  2C, relative humidity 50  5%, and 12-h light/dark cycle.
Drinking water and food were provided ad libitum throughout theScience and Engineering, Inje University, Gimhae 621-749, Korea.
 access under CC BY-NC-ND license. 
Table 1
Mortality of Spraguee-Dawley (SD) rats orally treated with red ginseng marc oil (RMO) in a single-dose safety
Sex Group/Dose (mg/kg) No. of animals Days after dosing Mortality, % (dead/total)
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Male RMO 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0/5)
RMO 5,000 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0/5)
Female RMO 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0/5)
RMO 5,000 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0/5)
Table 2
Summary of clinical signs 1 in rats exposed to red ginseng marc oil (RMO)
Sex Group/Dose
(mg/kg)
No. of
animals
Clinical signs Hours (Day 0)
after dosing
0.5 1 2 4 6
Male RMO 0 5 NOA 5 5 5 5 5
RMO 5,000 5 NOA 5 5 2 2 2
Soft stool 0 0 2 2 2
Compound-colored stool 0 0 1 1 1
Female RMO 0 5 NOA 5 5 5 5 5
RMO 5,000 5 NOA 5 4 4 4 4
Soft stool 0 1 1 1 1
Compound -colored stool 0 0 0 0 0
NOA, No Observable Abnormality.
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Used Committee of Inje University, Gimhae, South Korea. The ani-
mals were divided into four groups of ﬁve rats each upon receipt. As
no toxicological data were available regarding the safety of red
ginseng oil, the highest dosage level was selected as 5,000 mg/kg
according to the recommendations of the Korea Food and Drug
Administration Guidelines and the Organization for Economic Co-
Operation and Development (OECD) Guidelines [22,23]. Both male
and female rats were orally administered once at a dose of
5,000 mg/kg of RMO. In general, a nontoxic compound is recom-
mended to be tested up to 2,000 mg/kg or 5,000 mg/kg for acute
toxicity. Red ginseng is used as functional food and 5,000 mg/kg is
deemed to be a better choice for the current study rather than
2,000mg/kg, which is recommended as a maximumdose for drugs.
Based on many previous reports, the oral route administration is
probably the most convenient and commonly used one when
studying single oral dose safety [24e26].
In the present study, general symptoms, clinical signs, and
mortality rates were examined at the given RMO dose and then
daily for 14 d after the treatment. The clinical symptom is one of the
major important observations to indicate the side effects on organs
in the treated groups [27]. All groups treated with RMO did not
show any symptoms or abnormal clinical sings, and no deaths were
observed during the study period (Table 1), indicating that the
administration of the RMO has a negligible level of toxicity on theTable 3
Summary of clinical signs 2 in rats exposed to red ginseng marc oil (RMO)
Sex Group/ Dose (mg/kg) No. of animals Clinical signs
0
Male RMO 0 5 NOA 5
RMO 5,000 5 NOA 2
Soft stool 2
Compound-colored stool 1
Female RMO 0 5 NOA 5
RMO 5,000 5 NOA 4
Soft stool 1
Compound-colored stool 0
NOA, No Observable Abnormality.growth of the animals. In addition, no deaths or adverse clinical
signs were observed due to gavage of RMO at a dose of 5,000mg/kg
(Tables 2 and 3). Also, food intake and water consumptionwere not
affected by the administration of RMO (data not shown); moreover,
it did not induce appetite suppression and had no deleterious ef-
fects, indicating that there was no disturbance in carbohydrate,
protein, or fat metabolism.
Body weights were measured on the day of dosing (Day 0) prior
to treatment, 1 d, 2 d, 7 d, 13 d, and 14 d after dosing. Typically,
changes in body weight are one of the indicators of adverse effects
of testing substances, and it is considered signiﬁcant when body
weight loss is more than 10% from the initial weight [28]. In this
study, the body weight data indicated that there were no statisti-
cally signiﬁcant differences between RMO-treated groups and the
control groups throughout the experimental period (Fig. 1).
Furthermore, any decrease in body weight gain was not found in
the male and female rats treated with RMO. The above results for
single oral dose safety test suggest that RMO is safe and nontoxic to
rats at the dose of 5,000 mg/kg.
All animals survived during the experiment and were subjected
to terminal necropsy at the end of the experiment on Day 14.
Necropsy is a key procedure of most safety and/or toxicity studies,
and remarkable changes in tissues and organs are recorded during
this process [29]. No remarkable abnormalities were observed in
animal organs including the naked eyes, liver, kidneys, lung, heart,
thymus, spleen, adrenal glands, and reproductive organs (Table 4).
Therefore, we concluded that the lethality of RMO after a single oral
administration could be higher than 5,000 mg/kg in both male and
female rats under current experimental conditions. According to
the study of Jothy et al [27], substances with LD50 values higher
than 5,000 mg/kg by oral route are regarded as safe or practically
nontoxic [27]. Similar results were found for a single oral dose of
Coriolus versicolor water extract (5,000 mg/kg) that was shown to
be nontoxic to the tested SD rats [30]. Meanwhile, a study per-
formed by Fujii et al [31], in which Oligonol was used, revealed that
the extract did not cause any mortality up to 2,000 mg/kg and was
thus considered safe [31]. However, acute safety studies are
hampered by limitations in detecting test substance-related effects
on vital functions of cardiovascular, central nervous, and respira-
tory systems, which should be evaluated prior to human exposureDays after dosing
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Fig. 1. Body weight changes of rats exposed to a single-dose toxicity of red ginseng
marc oil (RMO). (A) Male and (B) female SpragueeDawley rats were administered
orally with RMO at doses of 5,000 mg/kg (-) on the day after dosing. Control animals
received the same amount of vehicle alone (A). Data are presented as mean  SD
(n ¼ 5). There was no signiﬁcant difference in body weight between RMO-treated
group and control group (p > 0.05). RMO, red ginseng marc oil; SD, standard deviation.
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Fig. 2. Hepatic parameters of rats exposed to a single-dose toxicity of red ginseng marc
oil (RMO). Male and female SpragueeDawley rats were administered orally with RMO
(5,000 mg/kg), and hepatotoxicity parameters including serum aspartate amino-
transferase (AST), alanine aminotransferase (ALT), and hepatic thiobarbituric acid
reactive substances (TBARS) values were determined at the end of the experiment on
Day 14. Data are presented as mean  SD (n ¼ 5). There was no signiﬁcant difference in
the hepatic parameters between RMO-treated group and control group (p > 0.05). SD,
standard deviation.
J Ginseng Res 2014;38:78e8180[32]. Further studies should be conducted to clarify the systemic
safety of RMO using repeated-dose safety pharmacology studies.
The enzymatic activities of serum aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) were used as biochemical
markers for hepatotoxicity. Blood samples from rats were centri-
fuged at 3,000  g at 4C for 10 min, and the AST and ALT activities
in serum supernatants were determined using a commercially
available kit (Youndong Pharm, Yong-In, South Korea). Hepatocel-
lular damage is characterized by a mutual rise in serum levels of
AST and ALT [33]. Liver is the main target organ of acute toxicity in
exposure to foreign substances being absorbed in intestines and
metabolized to other compounds that may or may not be hepato-
toxic to the mice [34]. There were no signiﬁcant changes in the
serum levels of AST and ALT after RMO administration, demon-
strating that liver function was preserved in male and female rats
exposed to RMO for 14 d (Fig. 2). Moreover, lipid peroxidation was
slightly decreased by the treatment of RMO (5,000 mg/kg), but not
signiﬁcantly. These data do not exhibit signiﬁcant differences
compared with the control group. Our results demonstrate that
RMO caused no hepatotoxic effects in male and female rats up to
5,000 mg/kg acutely.Table 4
Summary of necropsy ﬁndings in rats exposed to red ginseng marc oil (RMO)
Sex Male Female
Group G1 G2 G1 G2
Dose (mg/kg) 0 5,000 0 5,000
No. of animals 5 5 5 5
Unremarkable ﬁndings 5 5 5 5
No. of examined 5 5 5 5
External surface and all organs in body cavity were unremarkable.The present results show that RMO does not induce any
apparent in vivo damage in the current single oral dose safety study.
No death or signs of damage were observed in rats treated with
RMO at a dose of 5,000 mg/kg, thus establishing its safety in use. A
detailed experimental analysis of its chronic toxicity is essential for
further support of RMO.
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